Exane Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Exane Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-90,000	Closed	-$4.17M	–	56
2019 Q2	$4.17M	Buy	+90,000	New	+$2.53M	1.85%	18

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Exane Asset Management's ARRY Position: Q3 2019 in Review

Exane Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 90,000 shares — an estimated $4.17M sold.

Exane Asset Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $4.17M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Exane Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Exane Asset Management sold 90,000 Array Biopharma Inc shares in Q3 2019, an estimated $4.17M.
Exane Asset Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Exane Asset Management's Array Biopharma Inc position peaked at $4.17M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Exane Asset Management's 13F filing for Q3 2019, filed 24 Oct 2019.